SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001808665-21-000069
Filing Date
2021-08-05
Accepted
2021-08-05 16:46:50
Documents
89
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-20210630.htm   iXBRL 10-Q 1411648
2 EX-31.1 exhibit311-q22021.htm EX-31.1 11140
3 EX-31.2 exhibit312-q22021.htm EX-31.2 11063
4 EX-32.1 exhibit321-q22021.htm EX-32.1 6029
5 EX-32.2 exhibit322-q22021.htm EX-32.2 6269
  Complete submission text file 0001808665-21-000069.txt   7072741

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20210630.xsd EX-101.SCH 49023
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20210630_cal.xml EX-101.CAL 75331
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20210630_def.xml EX-101.DEF 253204
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20210630_lab.xml EX-101.LAB 553990
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20210630_pre.xml EX-101.PRE 384590
11 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20210630_htm.xml XML 1349426
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

IRS No.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39294 | Film No.: 211149086
SIC: 2834 Pharmaceutical Preparations